2018 IVF Policy
IVF is an assisted reproductive technology, which can help those couples who are difficult to conceive naturally to achieve their reproductive aspirations. Since IVF involves the manufacturing of human life and the rights and interests of infants in the world, the government has formulated a series of policies to regulate and manage the implementation of IVF. The following are some of the main provisions of China's IVF policy in 2018:
1. Legality and access standards of IVF technology
According to the 2018 IVF policy, only medical institutions with certain conditions can legally carry out IVF technology. These medical institutions need to have certain equipment and professional technology, and need to pass the review of relevant departments to obtain legal access. In addition, hospitals also need to have certain medical qualifications and clinical experience to ensure the safety and effectiveness of technical operations.
The government has also stipulated the access standards for IVF technology, for example, there are certain restrictions on women's age and physical conditions. Generally speaking, women should be at least 24 years old, healthy, and free from adverse genetic history or genetic diseases. In addition, the couple must have been married for at least 2 years, and indeed failed after a period of natural fertility attempts.
The 2018 policy also clearly stipulates that unmarried and same-sex couples are prohibited from enjoying IVF technology. IVF technology can only be enjoyed by legally married couples, and must be their genetic offspring. This provision is intended to protect the rights and legitimacy of children.
2. Ethical and legal constraints of IVF technology
The government has also set some ethical and legal constraints on the implementation of IVF technology. First, doctors must abide by medical ethics, respect patients' right to choose and know, and avoid excessive intervention and abuse of IVF technology.
Secondly, the government clearly stipulates that the use of IVF technology must comply with medical ethics and laws and regulations, and the use of illegal means, falsification of information and diagnosis is prohibited. In addition, the government has also made clear provisions on the treatment of IVF embryos, prohibiting the sex selection of fetuses, the treatment of excess embryos and other ethical violations.
3. Supervision and security of IVF technology
In order to ensure the safety and reliability of IVF technology, the government requires medical institutions to establish corresponding quality management systems and accept the assessment and supervision of relevant departments every year. Medical institutions must ensure the safety and accuracy of equipment, and provide professional training for medical personnel to ensure the correctness of technical operation.
The government also requires medical institutions to establish IVF technical files and strictly manage and protect relevant private information. The government requires medical institutions to record the time, operation and information of the implementation of IVF technology for reference and supervision.
4. Social responsibility and education publicity of IVF technology
The government emphasizes the social responsibility and education publicity of medical institutions for IVF technology. Medical institutions need to introduce the indications and risks of IVF technology to patients to ensure that patients clearly understand and make informed decisions.
The government requires medical institutions to carry out the publicity and education of IVF technology to improve the public's awareness and understanding of IVF technology. Medical institutions should also strengthen psychological support and social counseling for IVF families to help them cope with possible fertility problems and family pressure.
Summary
To sum up, the 2018 IVF policy mainly focuses on the legality and access standards of IVF technology, ethical and legal constraints, supervision and security, and social responsibility and education publicity. These policies will help ensure the safety and reliability of IVF technology, protect the rights and legitimacy of children, and promote the healthy development of reproductive medicine.
